Company Encyclopedia
View More
name
Raffles Medical
BSL.SG
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through four segments: Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services. Its Raffles Hospital, a tertiary care hospital that offers 24-hour acute and critical care, family medicine services, health screening, and a range of multi-disciplinary specialist clinics; appointed wards, day surgery, angiography suites, delivery suites, operating theatres, intensive care unit, and neonatal intensive care unit; and radiology, clinical laboratory, pharmacy, dietetics, rehabilitation, and traditional Chinese medicine, as well as dental services and emergency services. The company also trades in pharmaceutical and nutraceutical products, and diagnostic equipment; and provides management and consultancy services.
51.23 B
BSL.SGMarket value -Rank by Market Cap -/-

Financial Score

09/12/2025 Update
B
Health Care FacilitiesIndustry
Industry Ranking3/8
Industry medianC
Industry averageB
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE6.26%C
    • Profit Margin8.33%B
    • Gross Margin45.95%B
  • Growth ScoreC
    • Revenue YoY8.85%B
    • Net Profit YoY4.54%C
    • Total Assets YoY-1.84%D
    • Net Assets YoY0.35%C
  • Cash ScoreB
    • Cash Flow Margin1201.05%B
    • OCF YoY8.85%B
  • Operating ScoreC
    • Turnover0.51C
  • Debt ScoreB
    • Gearing Ratio30.55%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Stock Analysis: Raffles Medical Group | Lianhe Zaobao

    Raffles Medical Group recommends buying, with a target price of SGD 1.32 and a closing price of SGD 0.995 (+1.01%). The group is a comprehensive private healthcare service provider, primarily operating in Singapore and has expanded to China. The new Chief Financial Officer Woo Yeng Yeng has 20 years of experience, and her appointment will drive strategic initiatives and profitability in China. Maintain buy rating, as the stock price is supported by share buybacks and stable business

    Zaobao·
    SG
    BSL
    -0.51%
    Zaobao·
    SG
    BSL
    -0.51%

    Raffles Medical Group appoints Woo Yeng Yeng as CFO

    Raffles Medical Group has appointed Woo Yeng Yeng as its new Chief Financial Officer, effective immediately. Woo brings over 20 years of finance experience in sectors such as real estate, hospitality, and capital markets. She previously served as CFO and Head of Investor Relations at PARAGON REIT and held the role of Head of Finance at CapitaLand Investment (International). Woo holds a Bachelor of Accountancy from Nanyang Technological University and a Master of Commerce from the University of New South Wales, and is a chartered accountant of Singapore.

    Singapore Business Review·
    SG
    BSL
    -0.51%
    Singapore Business Review·
    SG
    BSL
    -0.51%

    DBS Remains a Buy on Raffles Medical Group (RAFLF)

    According to TipRanks, Tan is a 4-star analyst with an average return of 13.1% and a 73.68% success rate. Tan covers the Technology sector, focusing on stocks such as AEM Holdings Ltd., Intel, and Grand Venture Technology Limited. Currently, the analyst consensus on Raffles Medical Group is a Moderate Buy with an average price target of $0.93.

    Tip Ranks·
    SG
    BSL
    -0.51%
    Tip Ranks·
    SG
    BSL
    -0.51%

    Raffles Medical Group Appoints Woo Yeng Yeng As Chief Financial Officer

    Raffles Medical Group Ltd :RAFFLES MEDICAL GROUP LTD APPOINTMENT OF MS WOO YENG YENG AS CHIEF FINANCIAL OFFICER

    Reuters·
    SG
    BSL
    -0.51%
    Reuters·
    SG
    BSL
    -0.51%

    Raffles Medical Group names new Chief Technology Officer

    Foo holds a degree in Computer Science and Information Systems from NUS.Raffles Medical Group has named Terence Foo as its new Chief Technology Officer.Before his appointment, Foo was Executive Director of Deloitte Technology and Transformation, South-East Asia.In addition, he spent 25 years at Accenture prior to his role at Deloitte Consulting.Foo holds a degree in Computer Science and Information Systems from the National University of Singapore.

    Singapore Business Review·
    SG
    BSL
    -0.51%
    Singapore Business Review·
    SG
    BSL
    -0.51%
    © 2025 Longbridge｜Disclaimer